Top

Journal of Cancer Research and Clinical Oncology

Published in:

01-12-2019 | Biomarkers | Review – Cancer Research

Oncogenic potential of nucleoporins in non-hematological cancers: recent update beyond chromosome translocation and gene fusion

Authors: Adhiraj Roy, Gopeshwar Narayan

Published in: Journal of Cancer Research and Clinical Oncology | Issue 12/2019

Abstract

Introduction

The nuclear pore complex is comprised of approximately 30 proteins named nucleoporins (Nups) and tightly regulates nucleocytoplasmic transport of macromolecules across the nuclear membrane. Genetic alterations in many NUP genes are associated with many human maladies, such as neurological disease, autoimmune disorders and cancer.

Methods

We reviewed the status quo of recent advancement of the knowledge of oncogenic role of nucleoporins in human carcinogenesis, focusing on major non-hematological malignancies in the recent literature. Both clinical study-derived and experiment-based reports were critically reviewed. We have also discussed the potential of nucleoporins as novel cancer biomarkers and promising therapeutic target against human malignancies.

Results

Several Nups such as Nup53, Nup88, Nup98, Nup160 and Nup214 modulated a plethora of cellular and physiological pathways involved in tumorigenesis such as GSK3β-Snail, Wnt/β-Catenin and RanGap1/RanBP2 signaling axes, DNA damage response, resistance to apoptosis and chemotherapy.

Conclusion

Although classically, majority of studies have shown oncogenic roles of nucleoporins as genetic fusion partners in several types of leukemia, emerging evidence suggests that nucleoporins also modulate many cellular signaling pathways that are associated with several major non-hematological malignancies, such as carcinomas of skin, breast, lung, prostate and colon. Hence, nucleoporins are emerging as novel therapeutic targets in human tumors.

Agudo D, Gomez-Esquer F, Martinez-Arribas F, Nunez-Villar MJ, Pollan M, Schneider J (2004) Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer. Int J Cancer 109(5):717–720PubMed

Aitchison JD, Rout MP (2012) The yeast nuclear pore complex and transport through it. Genetics 190(3):855–883PubMedPubMedCentral

Akkafa F, Koyuncu I, Temiz E, Dagli H, Dilmec F, Akbas H (2018) miRNA-mediated apoptosis activation through TMEM 48 inhibition in A549 cell line. Biochem Biophys Res Commun 503(1):323–329PubMed

Alanee S, Delfino K, Wilber A, Robinson K, Brard L, Semaan A (2017) Single nucleotide variant in nucleoporin 107 may be predictive of sensitivity to chemotherapy in patients with ovarian cancer. Pharmacogenet Genom 27(7):264–269

Basel-Vanagaite L, Muncher L, Straussberg R, Pasmanik-Chor M, Yahav M, Rainshtein L, Walsh CA, Magal N, Taub E, Drasinover V et al (2006) Mutated nup62 causes autosomal recessive infantile bilateral striatal necrosis. Ann Neurol 60(2):214–222PubMed

Bhattacharjya S, Roy KS, Ganguly A, Sarkar S, Panda CK, Bhattacharyya D, Bhattacharyya NP, Roychoudhury S (2015) Inhibition of nucleoporin member Nup214 expression by miR-133b perturbs mitotic timing and leads to cell death. Mol Cancer 14:42PubMedPubMedCentral

Bonnet A, Palancade B (2014) Regulation of mRNA trafficking by nuclear pore complexes. Genes 5(3):767–791PubMedPubMedCentral

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA 68(6):394–424PubMed

Brustmann H, Hager M (2009) Nucleoporin 88 expression in normal and neoplastic squamous epithelia of the uterine cervix. Ann Diagn Pathol 13(5):303–307PubMed

Bui KH, von Appen A, DiGuilio AL, Ori A, Sparks L, Mackmull MT, Bock T, Hagen W, Andres-Pons A, Glavy JS et al (2013) Integrated structural analysis of the human nuclear pore complex scaffold. Cell 155(6):1233–1243PubMed

Choi YL, Lira ME, Hong M, Kim RN, Choi SJ, Song JY, Pandy K, Mann DL, Stahl JA, Peckham HE et al (2014) A novel fusion of TPR and ALK in lung adenocarcinoma. J Thorac Oncol 9(4):563–566PubMed

Closa A, Cordero D, Sanz-Pamplona R, Sole X, Crous-Bou M, Pare-Brunet L, Berenguer A, Guino E, Lopez-Doriga A, Guardiola J et al (2014) Identification of candidate susceptibility genes for colorectal cancer through eQTL analysis. Carcinogenesis 35(9):2039–2046PubMedPubMedCentral

Emig S, Schmalz D, Shakibaei M, Buchner K (1995) The nuclear pore complex protein p62 is one of several sialic acid-containing proteins of the nuclear envelope. J Biol Chem 270(23):13787–13793PubMed

Emterling A, Skoglund J, Arbman G, Schneider J, Evertsson S, Carstensen J, Zhang H, Sun XF (2003) Clinicopathological significance of Nup88 expression in patients with colorectal cancer. Oncology 64(4):361–369PubMed

Fradkin LG, Budnik V (2016) This bud’s for you: mechanisms of cellular nucleocytoplasmic trafficking via nuclear envelope budding. Curr Opin Cell Biol 41:125–131PubMedPubMedCentral

Gasset-Rosa F, Chillon-Marinas C, Goginashvili A, Atwal RS, Artates JW, Tabet R, Wheeler VC, Bang AG, Cleveland DW, Lagier-Tourenne C (2017) Polyglutamine-expanded huntingtin exacerbates age-related disruption of nuclear integrity and nucleocytoplasmic transport. Neuron. 94(1):48–57PubMedPubMedCentral

Gough SM, Slape CI, Aplan PD (2011) NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Blood 118(24):6247–6257PubMedPubMedCentral

Gould VE, Orucevic A, Zentgraf H, Gattuso P, Martinez N, Alonso A (2002) Nup88 (karyoporin) in human malignant neoplasms and dysplasias: correlations of immunostaining of tissue sections, cytologic smears, and immunoblot analysis. Hum Pathol 33(5):536–544PubMed

Greco A, Miranda C, Pagliardini S, Fusetti L, Bongarzone I, Pierotti MA (1997) Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes. Genes Chromosom Cancer 19(2):112–123PubMed

Grima JC, Daigle JG, Arbez N, Cunningham KC, Zhang K, Ochaba J, Geater C, Morozko E, Stocksdale J, Glatzer JC et al (2017) Mutant Huntingtin Disrupts the Nuclear Pore Complex. Neuron. 94(1):93–107PubMedPubMedCentral

Hazawa M, Lin DC, Kobayashi A, Jiang YY, Xu L, Dewi FRP, Mohamed MS, Hartono Nakada M, Meguro-Horike M et al (2018) ROCK-dependent phosphorylation of NUP62 regulates p63 nuclear transport and squamous cell carcinoma proliferation. EMBO Rep 19(1):73–88PubMed

Juhlen R, Fahrenkrog B (2018) Moonlighting nuclear pore proteins: tissue-specific nucleoporin function in health and disease. Histochem Cell Biol 150(6):593–605PubMed

Kabachinski G, Schwartz TU (2015) The nuclear pore complex–structure and function at a glance. J Cell Sci 128(3):423–429PubMedPubMedCentral

Karacosta LG, Kuroski LA, Hofmann WA, Azabdaftari G, Mastri M, Gocher AM, Dai S, Hoste AJ, Edelman AM (2016) Nucleoporin 62 and Ca(2 +)/calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells. Prostate 76(3):294–306PubMed

Karakoula K, Suarez-Merino B, Ward S, Phipps KP, Harkness W, Hayward R, Thompson D, Jacques TS, Harding B, Beck J et al (2008) Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13. Genes Chromosom Cancer 47(11):1005–1022PubMed

Kikutake C, Yahara K (2016) Identification of epigenetic biomarkers of lung adenocarcinoma through multi-omics data analysis. PLoS One 11(4):e0152918PubMedPubMedCentral

Kim NH, Pham NB, Quinn RJ, Shim JS, Cho H, Cho SM, Park SW, Kim JH, Seok SH, Oh JW et al (2015) The small molecule R-(-)-beta-O-methylsynephrine binds to nucleoporin 153 kDa and inhibits angiogenesis. Int J Biol Sci 11(9):1088–1099PubMedPubMedCentral

Kinoshita Y, Ito H, Hirano A, Fujita K, Wate R, Nakamura M, Kaneko S, Nakano S, Kusaka H (2009) Nuclear contour irregularity and abnormal transporter protein distribution in anterior horn cells in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 68(11):1184–1192PubMed

Kinoshita Y, Kalir T, Rahaman J, Dottino P, Kohtz DS (2012) Alterations in nuclear pore architecture allow cancer cell entry into or exit from drug-resistant dormancy. Am J Pathol 180(1):375–389PubMedPubMedCentral

Kinoshita Y, Hunter RG, Gray JD, Mesias R, McEwen BS, Benson DL, Kohtz DS (2014) Role for NUP62 depletion and PYK2 redistribution in dendritic retraction resulting from chronic stress. Proc Natl Acad Sci USA 111(45):16130–16135PubMed

Knoess M, Kurz AK, Goreva O, Bektas N, Breuhahn K, Odenthal M, Schirmacher P, Dienes HP, Bock CT, Zentgraf H et al (2006) Nucleoporin 88 expression in hepatitis B and C virus-related liver diseases. World J Gastroenterol 12(36):5870–5874PubMedPubMedCentral

Kraemer D, Wozniak RW, Blobel G, Radu A (1994) The human CAN protein, a putative oncogene product associated with myeloid leukemogenesis, is a nuclear pore complex protein that faces the cytoplasm. Proc Natl Acad Sci USA 91(4):1519–1523PubMed

Labade AS, Karmodiya K, Sengupta K (2016) HOXA repression is mediated by nucleoporin Nup93 assisted by its interactors Nup188 and Nup205. Epigenetics Chromatin 9:54PubMedPubMedCentral

Laurell E, Beck K, Krupina K, Theerthagiri G, Bodenmiller B, Horvath P, Aebersold R, Antonin W, Kutay U (2011) Phosphorylation of Nup98 by multiple kinases is crucial for NPC disassembly during mitotic entry. Cell 144(4):539–550PubMed

Li F, Zhai YP, Tang YM, Wang LP, Wan PJ (2012) Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome. Genes Chromosom Cancer 51(9):890–897PubMed

Liashkovich I, Pasrednik D, Prystopiuk V, Rosso G, Oberleithner H, Shahin V (2015) Clathrin inhibitor Pitstop-2 disrupts the nuclear pore complex permeability barrier. Sci Rep 5:9994PubMedPubMedCentral

Lim KS, Wong RW (2018) Targeting nucleoporin POM121-Importin beta axis in prostate cancer. Cell Chem Biol 25(9):1056–1058PubMed

Lu T, Bao Z, Wang Y, Yang L, Lu B, Yan K, Wang S, Wei H, Zhang Z, Cui G (2016) Karyopherinbeta1 regulates proliferation of human glioma cells via Wnt/beta-catenin pathway. Biochem Biophys Res Commun 478(3):1189–1197PubMed

Makise M, Nakamura H, Kuniyasu A (2018) The role of vimentin in the tumor marker Nup88-dependent multinucleated phenotype. BMC Cancer 18(1):519PubMedPubMedCentral

Makiyama K, Hamada J, Takada M, Murakawa K, Takahashi Y, Tada M, Tamoto E, Shindo G, Matsunaga A, Teramoto K et al (2005) Aberrant expression of HOX genes in human invasive breast carcinoma. Oncol Rep 13(4):673–679PubMed

Martinez N, Alonso A, Moragues MD, Ponton J, Schneider J (1999) The nuclear pore complex protein Nup88 is overexpressed in tumor cells. Cancer Res 59(21):5408–5411PubMed

Mohamed MS, Kobayashi A, Taoka A, Watanabe-Nakayama T, Kikuchi Y, Hazawa M, Minamoto T, Fukumori Y, Kodera N, Uchihashi T et al (2017) High-speed atomic force microscopy reveals loss of nuclear pore resilience as a dying code in colorectal cancer cells. ACS Nano 11(6):5567–5578PubMed

Mullan PB, Bingham V, Haddock P, Irwin GW, Kay E, McQuaid S, Buckley NE (2019) NUP98—a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer. BMC Cancer 19(1):236PubMedPubMedCentral

Naylor RM, Jeganathan KB, Cao X, van Deursen JM (2016) Nuclear pore protein NUP88 activates anaphase-promoting complex to promote aneuploidy. J Clin Investig 126(2):543–559PubMed

Nofrini V, Di Giacomo D, Mecucci C (2016) Nucleoporin genes in human diseases. Eur J Hum Genet 24(10):1388–1395PubMedPubMedCentral

Pante N, Fahrenkrog B (2014) Exploring nuclear pore complex molecular architecture by immuno-electron microscopy using Xenopus oocytes. Methods Cell Biol 122:81–98PubMed

Re A, Colussi C, Nanni S, Aiello A, Bacci L, Grassi C, Pontecorvi A, Farsetti A (2018) Nucleoporin 153 regulates estrogen-dependent nuclear translocation of endothelial nitric oxide synthase and estrogen receptor beta in prostate cancer. Oncotarget 9(46):27985–27997PubMedPubMedCentral

Rodriguez-Bravo V, Pippa R, Song WM, Carceles-Cordon M, Dominguez-Andres A, Fujiwara N, Woo J, Koh AP, Ertel A, Lokareddy RK et al (2018) Nuclear pores promote lethal prostate cancer by increasing POM121-driven E2F1, MYC, and AR nuclear import. Cell 174(5):1200–1215PubMedPubMedCentral

Ryan KJ, White CC, Patel K, Xu J, Olah M, Replogle JM, Frangieh M, Cimpean M, Winn P, McHenry A et al (2017) A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variants. Sci Transl Med 9(421):eaai7635PubMedPubMedCentral

Sakuma S, D’Angelo MA (2017) The roles of the nuclear pore complex in cellular dysfunction, aging and disease. Semin Cell Dev Biol 68:72–84PubMedPubMedCentral

Sheffield LG, Miskiewicz HB, Tannenbaum LB, Mirra SS (2006) Nuclear pore complex proteins in Alzheimer disease. J Neuropathol Exp Neurol 65(1):45–54PubMed

Shen Q, Yu M, Jia J-K, Li W-X, Tian Y-W, Xue H-Z (2018) Possible molecular markers for the diagnosis of pancreatic ductal adenocarcinoma. Med Sci Monit 24:2368–2376PubMedPubMedCentral

Shi J, Li C, Wang H, Xiao B, Qiu W (2019) NUP58 facilitates metastasis and epithelial-mesenchymal transition of lung adenocarcinoma via the GSK-3beta/Snail signaling pathway. Am J Transl Res 11(1):393–405PubMedPubMedCentral

Soman NR, Correa P, Ruiz BA, Wogan GN (1991) The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. Proc Natl Acad Sci USA 88(11):4892–4896PubMed

Takahashi N, van Kilsdonk JW, Ostendorf B, Smeets R, Bruggeman SW, Alonso A, van de Loo F, Schneider M, van den Berg WB, Swart GW (2008) Tumor marker nucleoporin 88 kDa regulates nucleocytoplasmic transport of NF-kappaB. Biochem Biophys Res Commun 374(3):424–430PubMed

Takeda A, Yaseen NR (2014) Nucleoporins and nucleocytoplasmic transport in hematologic malignancies. Semin Cancer Biol 27:3–10PubMed

Takeshima H, Wakabayashi M, Hattori N, Yamashita S, Ushijima T (2015) Identification of coexistence of DNA methylation and H3K27me3 specifically in cancer cells as a promising target for epigenetic therapy. Carcinogenesis 36(2):192–201PubMed

Tan X, Zhou L, Wang W, Wang B, Egami H, Baba H, Dai X (2010) Genomic analysis of invasion-metastasis-related factors in pancreatic cancer cells. Exp Ther Med 1(1):211–216PubMedPubMedCentral

Tian C, Zhou S, Yi C (2018) High NUP43 expression might independently predict poor overall survival in luminal A and in HER2 + breast cancer. Future Oncol 14(15):1431–1442PubMed

von Lindern M, van Baal S, Wiegant J, Raap A, Hagemeijer A, Grosveld G (1992) Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3′ half to different genes: characterization of the set gene. Mol Cell Biol 12(8):3346–3355

Wente SR, Rout MP (2010) The nuclear pore complex and nuclear transport. Cold Spring Harb Perspect Biol 2(10):a000562PubMedPubMedCentral

Wu Y, Fang G, Wang X, Wang H, Chen W, Li L, Ye T, Gong L, Ke C, Cai Y (2019) NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/beta-catenin signaling pathway and predicts good prognosis. Cancer Biomark 24(1):61–70PubMed

Zhang H, Schneider J, Rosdahl I (2002) Expression of p16, p27, p53, p73 and Nup88 proteins in matched primary and metastatic melanoma cells. Int J Oncol 21(1):43–48PubMed

Zhang ZY, Zhao ZR, Jiang L, Li JC, Gao YM, Cui DS, Wang CJ, Schneider J, Wang MW, Sun XF (2007) Nup88 expression in normal mucosa, adenoma, primary adenocarcinoma and lymph node metastasis in the colorectum. Tumour Biol 28(2):93–99PubMed

Zhao ZR, Zhang ZY, He XQ, Hu YM, Tian YF, Zhang LJ, Sun XF (2010) Nup88 mRNA overexpression in colorectal cancers and relationship with p53. Cancer Biomark 8(2):73–80PubMed

Zhao ZR, Zhang LJ, Wang YY, Li F, Wang MW, Sun XF (2012) Increased serum level of Nup88 protein is associated with the development of colorectal cancer. Med Oncol 29(3):1789–1795PubMed

Zhou MH, Yang QM (2014) NUP214 fusion genes in acute leukemia (Review). Oncol Lett 8(3):959–962PubMedPubMedCentral

Title: Oncogenic potential of nucleoporins in non-hematological cancers: recent update beyond chromosome translocation and gene fusion
Authors: Adhiraj Roy
Gopeshwar Narayan
Publication date: 01-12-2019
Publisher: Springer Berlin Heidelberg
Keyword: Biomarkers
Published in: Journal of Cancer Research and Clinical Oncology / Issue 12/2019
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-019-03063-2

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Oncogenic potential of nucleoporins in non-hematological cancers: recent update beyond chromosome translocation and gene fusion

Abstract

Introduction

Methods

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 12/2019

Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma

Differential expression of p52 and RelB proteins in the metastatic and non-metastatic groups of uveal melanoma with patient outcome

ΔNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression

A systematic review of treatment outcomes in localised and metastatic spermatocytic tumors of the testis

Are shape morphologies associated with survival? A potential shape-based biomarker predicting survival in lung cancer

Therapeutic delivery of microRNA-143 by cationic lipoplexes for non-small cell lung cancer treatment in vivo

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page